GOSS
Gossamer Bio Inc
10.90$
-0.5%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -492.7% | – | 121.4% | -337.9% | -378.3% | -401.7% | -409.6% | -272.1% | -350.1% | -228.4% | -426.8% | -305.2% | |
| – | 14.8% | – | 1.0% | 11.6% | 11.5% | 3.5% | 1.9% | 1.7% | 1.6% | 1.4% | 0.0% | 1.3% | |
| – | 88.9% | – | 5.2% | 51.1% | 52.9% | 24.3% | 22.5% | 20.1% | 21.0% | 37.2% | 26.7% | 26.9% | |
| – | 14.2% | – | 66.6% | -42.7% | -59.2% | -34.5% | -86.1% | 22.8% | -24.4% | 10.7% | -85.4% | -12.0% | |
| – | 0.9% | – | 121.4% | 337.9% | 0.0% | 0.3% | 0.5% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| – | -211.8% | – | -61.7% | -282.2% | 567.4% | 223.1% | 384.1% | 128.0% | 530.2% | 245.4% | 462.2% | 327.4% | |
| – | 1.1% | – | – | 3.0% | – | 3.8% | – | 3.5% | – | 1.7% | – | – | |
| – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | |
| – | -42.8% | – | -9.6% | 3.0% | 0.0% | 5.1% | 0.8% | 14.1% | 28.7% | 3.0% | -34.0% | 6.0% | |
| – | -744.4% | – | 50.1% | -616.2% | 187.8% | -172.4% | -23.6% | -130.7% | 208.7% | 19.4% | 1.3% | 27.8% | |
| – | -492.7% | – | 121.4% | -337.9% | -378.3% | -402.0% | -410.1% | -272.1% | -350.1% | -228.4% | -426.8% | -305.2% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.